Concepedia

Author

A Diamantopoulos

Bayer (United Kingdom)

Also Known As

A Diamantopoulos, A. Diamantopoulos, Alex Diamantopoulos

47

Publications

348

Citations

9

H-Index

5

Concepts

All Affiliations

Bayer (United Kingdom)University of OttawaOttawa Hospital
AD

About

A Diamantopoulos is an author at Bayer (United Kingdom) specializing in hip arthroplasty, orthopaedics, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

14

2

Orthopaedics

1

1

14

3

Pain Management

1

1

14

4

Hip Arthroplasty

1

1

14

5

Surgery

1

1

14

A Diamantopoulos

×

7

Publications

152

Citations

7

H-Index

YearCitations

Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

Christoph Lohan, A Diamantopoulos, C LeReun,

BMJ Open Gastroenterology

2019

39

Cost–effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden

Lars Ryttberg, A Diamantopoulos, Fiona Forster,

Expert Review of Pharmacoeconomics & Outcomes Research

2011

31

Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK

A Diamantopoulos, Axel Finckh, T. Huizinga,

PharmacoEconomics

2014

27

Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective

Heather McDonald, A Diamantopoulos, Philip Wells,

Journal of Medical Economics

2012

21

Uncemented total hip replacements and thigh pain

G. Petrou, M. Gavras, A Diamantopoulos,

Archives of Orthopaedic and Trauma Surgery

1994

14

An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement

C LeReun, Philip Wells, A Diamantopoulos,

Journal of Medical Economics

2011

10

Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework

Bryony Langford, A Diamantopoulos, Toby M. Maher,

Advances in Therapy

2021

10

Page 1